Key pathology (n assessed) | Kappa (95% CI) | Sensitivity % (95% CI) | Specificity % (95% CI) | Positive predictive value % (95% CI) | Negative predictive value % (95% CI) |
---|---|---|---|---|---|
Pericardial effusion (n = 367) | − 0.03 (− 0.04, − 0.02) | 0 (0, 36.9) | 95.8 (93.2, 97.6) | 0 (0.00, 19.9) | 97.7 (97.7–97.8) |
Left ventricular dysfunction (n = 353) | 0.17 (0.07, 0.28) | 52.9 (36.2, 69.7) | 77.1 (72.5, 81.7) | 19.8 (11.6–28.0) | 93.9 (91.0–96.8) |
Aortic regurgitation (n = 343) | 0.28 (0.14, 0.41) | 29.6 (17.5, 41.8) | 93.8 (91.0, 96.6) | 47.1 (30.3–63.8) | 87.7 (84.0–91.4) |
Mitral valve regurgitation: moderate to severe (n = 354) | 0.29 (0.14, 0.44) | 57.1 (36.0, 78.3) | 89.2 (85.9, 92.5) | 25.0 (12.7–37.2) | 97.1 (95.2–99.0) |
Tricuspid valve regurgitation: moderate to severe (n = 334) | 0.42 (0.25, 0.59) | 59.1 (38.6, 79.6) | 93.3 (90.5, 96.1) | 38.2 (21.9–54.56) | 97.0 (95.1–98.9) |
Mitral valve stenosis: moderate to severe (n = 371) | 0 (0, 0) | N/A | 86.5 (82.6, 89.8) | N/A | N/A |